MetaCap

Anteris Technologies Global (AVR) vs JIN MEDICAL INTERNATIONAL LTD. (ZJYL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.

Summary

Anteris Technologies Global (AVR) has outperformed JIN MEDICAL INTERNATIONAL LTD. (ZJYL) over the past year, gaining 38.4% versus a loss of 76.3%. Anteris Technologies Global is the larger company by market cap ($659.8 million vs $153.8 million), about 4.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AVR+38.45%ZJYL-76.32%
+126%+18%-89%
Oct 9, 20251 yearOct 9, 2026
AVR+20.89%ZJYL-86.76%
+91%-3%-97%
Dec 9, 20245 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AVR versus ZJYL key metrics
MetricAVRZJYL
Share price$6.77$2.06
Market cap$659.79M$153.81M
1-day change+2.11%-2.83%
YTD return+35.67%-53.18%
1-year return+38.45%-76.32%
P/E ratio (TTM)—10.84
EPS (TTM)$-1.99$0.19
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$11.06$8.96
52-week low$3.30$1.53
Distance from 52-week high-38.76%-77.01%
Analyst consensusstrong_buy—
Avg. price target upside+106.79%—
Average volume945.17K723.33K
Shares outstanding97.46M73.66M
Employees174273
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Anteris Technologies Global is about 4.3 times larger than JIN MEDICAL INTERNATIONAL LTD. by market value ($659.79M vs $153.81M).
  • AVR has outperformed ZJYL by 114.8 percentage points over the past year.

About Anteris Technologies Global

AVR stock →

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.

Health Care · Industrial Specialties · 174 employees

About JIN MEDICAL INTERNATIONAL LTD.

ZJYL stock →

Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury.

Health Care · Industrial Specialties · 273 employees

AVR vs ZJYL FAQ

Which is bigger, Anteris Technologies Global or JIN MEDICAL INTERNATIONAL LTD.?

Anteris Technologies Global (AVR) is larger, with a market capitalization of $659.79M compared with $153.81M for JIN MEDICAL INTERNATIONAL LTD. (ZJYL).

Which stock has performed better over the past year, AVR or ZJYL?

AVR returned +38.45% over the past 12 months, compared with -76.32% for ZJYL (price return, excluding dividends). Past performance does not predict future results.

Are Anteris Technologies Global and JIN MEDICAL INTERNATIONAL LTD. in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons